Drug Intermediate Control

Drug Intermediate Controls (30):

Cat. No.	Product Name	Effect	Purity

HY-W098322

Z-Lys-OMe hydrochloride	Control	99.43%
Z-Lys-OMe hydrochloride is a synthetic intermediate that can be used in the synthesis of peptide enzyme substrates and lysine cationic surfactants.

HY-W048312

2'-Hydroxy-1'-acetonaphthone	Control	99.69%
2'-Hydroxy-1'-acetonaphthone is a Schiff base used as pharmaceutical intermediates.

HY-Z0085

2-Chloro-N-methyl-N-(4-nitrophenyl)acetamide	Control	99.58%
2-Chloro-N-methyl-N-(4-nitrophenyl)acetamide is a synthetic intermediate useful for pharmaceutical synthesis.

HY-W590911

Indole-3-amidoxime	Control
Indole-3-amidoxime is a synthetic intermediate useful for pharmaceutical synthesis.

HY-Y1118

6,7-Dihydroquinolin-8(5H)-one	Control	99.96%
6,7-Dihydroquinolin-8(5H)-one is a synthetic intermediate useful for pharmaceutical synthesis.

HY-W088629

D-2-Aminoglutarimide hydrochloride	Control
D-2-Aminoglutarimide hydrochloride is a synthetic intermediate that can be used in the synthesis of hydantoins with anti-angiogenic and cancer cell differentiation-inducing activities.

HY-W128579

2-Pyrimidinepropanoic acid	Control
2-Pyrimidinepropanoic acid is a synthetic intermediate useful for pharmaceutical synthesis.

HY-135638

Imatinib Acid	Control	99.73%
Imatinib Acid is an analogue of Imatinib (HY-15463).

HY-W144281

N'-Hydroxy-3-methylbenzenecarboximidamide	Control	≥98.0%
N'-Hydroxy-3-methylbenzenecarboximidamide is an intermediate useful for pharmaceutical synthesis.

HY-133681

(±)-2,3-Dibromosuccinic acid	Control
(±)-2,3-Dibromosuccinic acid is the key intermediate in the synthesis of dicarboxylic acid derivatives.

HY-Z9464

Fluprostenol lactone diol	Control
Fluprostenol lactone diol is an intermediate used in the preparation of Fluprostenol (HY-136494).

HY-W320685

(S)-N-Boc-L-homoserine ethyl ester	Control	98.0%
(S)-N-Boc-L-homoserine ethyl ester is a synthetic intermediate in the synthesis of unsaturated caprolactams and monomer units for oxy-peptide nucleic acids from the starting material L-homoserine.

HY-W094155

Methyl (1S)-3-oxocyclopentaneacetate	Control
Methyl (1S)-3-oxocyclopentaneacetate is a synthetic intermediate useful for pharmaceutical synthesis.

HY-W278906

Ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-carboxylate	Control
Ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-carboxylate is a synthetic intermediate useful for pharmaceutical synthesis.

HY-W327038

7-Piperazin-1-yl-thieno[2,3-c] pyridine hydrochloride	Control
7-Piperazin-1-yl-thieno[2,3-c] pyridine hydrochloride is a synthetic intermediate useful for pharmaceutical synthesis.

HY-W153810

2-Methyl-4-phenyl thiazole	Control
2-Methyl-4-phenyl thiazole is a synthetic intermediate useful for pharmaceutical synthesis.

HY-W063149

(1S,3R)-3-Aminocyclopentanol	Control
(1S,3R)-3-Aminocyclopentanol is a synthetic intermediate useful for pharmaceutical synthesis.

HY-W700710

(Rac)-7-Methoxy propranolol	Control
(Rac)-7-Methoxy propranolol is a synthetic intermediate useful for pharmaceutical synthesis.

HY-Z8648

Δ14-Triamcinolone acetonide	Control
Δ14-Triamcinolone acetonide is a potential impurity. Triamcinolone acetonide inhibits basic fibroblast growth factor (bFGF) induced proliferation of retinal endothelial cells. Triamcinolone acetonide reduces chondrocyte viability and leads to cartilage destruction. Triamcinolone acetonide can be used in the study of diseases such as atopic dermatitis.

HY-W088558

Benzyl (1R,3R)-3-hydroxycyclopentane-1-carboxylate	Control
Benzyl (1R,3R)-3-hydroxycyclopentane-1-carboxylate is a synthetic intermediate useful for pharmaceutical synthesis.

Name
Email *

	Sorry, but the email address you supplied was invalid.